<DOC>
	<DOCNO>NCT01022918</DOCNO>
	<brief_summary>Treatment glioblastoma ( GBM ) base surgery possible , chemoradiation temozolomide , become standard since EORTC study ( Stupp , 2005 ) . However , prognosis unresectable GBM remain poor despite chemoradiation estimate 10 month median survival , range comparable patient RPA class V EORTC study ( Miramanoff , 2006 ) . Vredenburgh et al . Duke University ( Durham , NC ) report ASCO 2006 ( fully publish J Clin Oncol , 2007 ) 57 % unexpected response rate use bevacizumab/irinotecan schedule patient relapse GBM grade 3 astrocytomas . This unusual high response rate , sometimes major sustained response , confirm cooperative french study ANOCEF ( Guiu et al. , 2008 ) . Such major improvement treatment effectiveness lead ANOCEF , federate active neuro-oncology team France , propose neo-adjuvant adjuvant bevacizumab-based chemotherapy frame standard temozolomide-based chemoradiation aim improve prognosis unresectable GBM . The bevacizumab/temozolomide combination neo-adjuvant presently evaluate Duke University . We believe ambitious comparison bevacizumab/irinotecan-schedule `` standard '' temozolomide-based chemoradiation fascinating challenge improve treatment awful disease . The ANOCEF proposal `` Evaluation irinotecan/bevacizumab association neo-adjuvant adjuvant treatment chemoradiation temozolomide naive unresectable glioblastoma . Phase II randomize study comparison chemoradiation temozolomide '' successfully grant INCA ( Institut National du Fancer , France ) research program ( PHRC : Programme Hospitalier de Recherche Clinique ) . Implementation program starting .</brief_summary>
	<brief_title>Evaluation Irinotecan/Bevacizumab Association Naive Unresectable Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>All eligibility criterion must meet registration : delay upper equal 14 day stereotaxic biopsy 28 day surgical biopsy Histopathologically proven diagnosis glioblastoma ( WHO grade IV astrocytoma ) Patient belong RPA V class associate supratentorial glioblastoma Diagnosis must obtain stereotactic surgical biopsy Age 18 70 A contrastenhanced MRI must perform within 28 day prior study registration Total partial surgical resection deem possible neurosurgeon Karnofsky Index ( KI ) performance status 50 Life expectancy least 3 month A stable dose corticosteroid least 7 day control intracranial pressure neurological symptom Adequate blood function : absolute neutrophil count &gt; 1.5 x 109/L , platelet count &gt; 100 x 109/L platelet ; hemoglobin &gt; 10 g/dl blood transfusion require Adequate liver function : bilirubin &lt; 1.5 ULN ( upper limit normal ) , ALT AST &lt; 2.5 ULN , Prothrombin rate &gt; 75 % Adequate renal function : creatinine &lt; 1.2 ULN ; proteinuria test 0 trace ( urine protein concentration &lt; 1g/24h proteinuria test + ++ ) . Negative pregnancy test woman childbearing potential adequate contraception men woman . systolic arterial blood pressure rest ≤ 170 mmHg Patient must inform must sign specific inform consent form . holder coverage health insurance patient belong RPA III IV prior malignant tumor recent 5 year concomitant malignancy prior antitumoral chemotherapy radiotherapy prior gross resection brain tumor patient receive gliadel cardiovascular contraindication bevacizumab : prior angina pectoris , prior myocardial infarction , prior brain stroke , even transient , distal severe arteriopathy , uncontrolled high blood pressure anticomitial drug p450 cytochrome inductor substance induce p450 cytochrome proteinuria ≥ 1g/L concurrent anticoagulant platelet antiaggregant treatment congenital haemorrhagic pathology ( haemophilia , Willebrandt ) sign brain haemorrhage RMI initial exam non resolve infectious disease non control arterial hypertension ( ≥170 mmHg ) intracranial high pressure control stable dose steroid least 7 day pregnancy refusal contraception woman men psychiatric , behavioural disorder geographical situation preclude administration followup protocol ( include claustrophobia ) digestive haemorrhage / gastroduodenal ulcer occur last 3 month pregnant , nurse woman , without contraception private individual freedom tutelage ( include legal guardianship )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>unresectable glioblastoma</keyword>
</DOC>